Background: Lobectomy is the generally accepted standard treatment for early-stage non-small cell lung cancer (NSCLC). However, especially in elderly patients, it is often necessary to perform pneumonectomy in order to maximize the likelihood of curative treatment, although pneumonectomy is a challenging procedure. Methods: We analysed patients who were clinically diagnosed with stage I NSCLC and underwent pneumonectomy with curative intent from 2004 to 2011. The patients were divided into an elderly group (≥70 years) and a younger group (＜70 years). We retrospectively analysed the outcomes of these groups of patients in order to characterize the role of pneumonectomy as a treatment for elderly patients with clinical stage I NSCLC. Results: Thirty patients younger than 70 years of age (younger group) and fourteen patients 70 years of age or older (elderly group) who underwent pneumonectomy were enrolled in the present study. The median follow-up period was 35 months (range, 0 to 125 months). The perioperative mortality rate (within 90 days after the operation) was 7.1% in the elderly group and 6.7% in the younger group (p=0.73). No significant differences between the two groups were observed regarding the occurrence of pneumonia, acute respiratory distress syndrome, cardiac arrhythmia, bronchopleural fistula, and vocal cord paralysis. The overall five-year survival rate was 79.4% in the younger group and 35.7% in the elderly group, which was a significant difference (p=0.018). The five-year disease-free survival rate was 66.7% in the younger group and 35.7% in the elderly group, but this difference was not statistically significant (p=0.23). Conclusion: Although elderly patients with early stage lung cancer showed a worse long-term survival rate after pneumonectomy than younger patients, the outcomes of elderly patients were similar to those of younger patients in terms of perioperative mortality and postoperative complications. Patients should not be denied pneumonectomy solely due to old age.
INTRODUCTION
Non-small cell lung cancer is the leading cause of cancer-related death in both men and women older than 65 years in Western countries [1] , and an increasing number of patients suffer from this disease. Surgical resection is the most effective treatment for early-stage non-small cell lung cancer (NSCLC), and lobectomy is the standard surgical technique for treating NSCLC. Nonetheless, in some instances pneumonectomy is the only surgical option for curative resection in patients who require the removal of more than one lobe in order to accomplish a complete resection. However, pneumonectomy itself is associated with higher rates of morbidity and mortality than other standard procedures [2] [3] [4] [5] . Most surgeons try to avoid pneumonectomy as much as possible due to these potential adverse outcomes, especially among elderly patients. Moreover, NSCLC is often diagnosed in elderly patients [6] . Thus, an older population is expected to have an increasing risk of lung cancer, and elderly patients must often undergo pneumonectomy for the treatment of lung cancer.
However, it is not clear whether elderly patients obtain the same benefits from major surgical procedures, especially pneumonectomy, as younger patients. Recent evidence shows that pneumonectomy in elderly patients with lung cancer appears to be justified because its outcomes are comparable to those observed in younger patients [7, 8] . In this study, we retrospectively evaluated the clinical outcomes of patients at least 70 years of age who underwent pneumonectomy for clinical stage I NSCLC.
METHODS

1) Patients and data collection
We performed a retrospective review of all patients who Postoperatively, the follow-up schedule involved visits to the clinic every three to four months during the first two years, and every four to six months from the third to the fifth years. The usual follow-up procedures included a physical examination and a chest CT scan. FDG-PET CT imaging was performed annually.
3) Statistical analysis
For comparisons of continuous and categorical variables, the Mann-Whitney U-test, the chi-square test, or the Fisher's exact test were used, depending on which as appropriate.
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RESULTS
A total of 44 patients were analysed, and their characteristics are summarized in Table 1 . The median follow-up peri- la, and vocal cord paralysis) ( Table 3 ).
The overall five-year survival rates were 79.4% for the younger group and 35.7% for the elderly group. The overall survival rate was significantly higher in the younger group than in the elderly group (p=0.018) (Fig. 1) . The five-year disease-free survival rate was 66.7% for the younger group and 35.7% for the elderly group. The disease-free survival rate was not significantly different between the younger and elderly group (p=0.23) (Fig. 2) .
DISCUSSION
Non-small cell lung cancer is the leading cause of cancer-related death in both men and women older than 65 years in Western countries [1] . Despite recent developments in chemotherapy and radiotherapy, surgical resection for stage I or II disease remains the only reliably curative treatment [9] .
The Korean population is increasing in age, and elderly age is still regarded as a major risk factor for surgery. Elderly patients tend to be denied surgery or are urged to undergo palliative treatment. It has been found that 92.3% of patients younger than 75 years of age received curative surgery for stage I NSCLC, compared to only 69.6% of patients over 75 years of age [10] .
Questions remain about the real risks of lung resection surgery, especially in elderly patients. Some studies have assessed the role of surgery in elderly patients with NSCLC.
Cerfolio and Bryant [11] , in a nested case-control study published in 2006, reported that the overall five-year survival in elderly patients (≥70 years of age) was 78%, which was significantly higher than the rate in the younger group (69%, p=0.01), and concluded that elderly patients with early NSCLC should not be denied pulmonary resection. In contrast, another study found a higher postoperative death rate among elderly patients undergoing pneumonectomy [12] . The results of our study showed no significant differences between the two groups (younger vs. elderly) regarding perioperative mortality and morbidity. However, the overall five-year survival rate was significantly higher in the younger Tae Ho Kim, et al
group than in the elderly group, while disease-free survival was not significantly different between the two groups.
Goodgame et al. [13] conducted a retrospective study of stage I NSCLC and found that elderly patients have similar recurrence-free survival rate, but worse overall survival than younger patients (five-year survival, 52% vs. 67%; p＜0.0001), which was similar to our results. Birim et al. [14] found that increasing age was a significant prognostic factor affecting long-term outcomes, along with other metrics such as the 
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